US 12,186,550 B2
Resilient body component contact for a subcutaneous device
Yatheendhar D. Manicka, Woodbury, MN (US)
Assigned to Manicka Institute LLC, Woodbury, MN (US)
Filed by Manicka Institute LLC, Woodbury, MN (US)
Filed on Dec. 23, 2022, as Appl. No. 18/088,421.
Application 17/105,447 is a division of application No. 16/051,451, filed on Jul. 31, 2018, granted, now 10,471,251, issued on Nov. 12, 2019.
Application 18/088,421 is a continuation of application No. 17/139,740, filed on Dec. 31, 2020, granted, now 11,660,444.
Application 17/139,740 is a continuation of application No. 17/105,447, filed on Nov. 25, 2020, granted, now 11,433,233, issued on Sep. 6, 2022.
Application 17/139,740 is a continuation of application No. 16/355,236, filed on Mar. 15, 2019, granted, now 10,894,155, issued on Jan. 19, 2021.
Prior Publication US 2023/0130587 A1, Apr. 27, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/05 (2006.01); A61B 5/283 (2021.01); A61B 5/349 (2021.01); A61B 17/3211 (2006.01); A61M 5/142 (2006.01); A61N 1/372 (2006.01); A61N 1/375 (2006.01); A61N 1/39 (2006.01)
CPC A61N 1/0504 (2013.01) [A61B 5/283 (2021.01); A61B 5/349 (2021.01); A61B 17/3211 (2013.01); A61M 5/14276 (2013.01); A61N 1/059 (2013.01); A61N 1/37211 (2013.01); A61N 1/37252 (2013.01); A61N 1/37518 (2017.08); A61N 1/3956 (2013.01)] 28 Claims
OG exemplary drawing
 
1. A subcutaneously implantable device comprising:
a housing that is implantable into a body of a patient and is securable to a muscle, a bone and/or a first tissue of the patient underneath the patient's skin and outside of an organ of the patient that is targeted for monitoring, therapy, and/or diagnosis;
a prong attached to the housing at a proximal end of the prong, the prong having a contact portion at or adjacent to a distal end of the prong that is configured to contact the organ, wherein the prong is constructed to apply pressure to the organ with spring action so as to maintain contact between the contact portion and the organ without fixing the contact portion to the organ;
an electrode at the contact portion of the prong, the electrode being configured to contact the organ and being electrically coupled or couplable with circuitry that is configured to provide monitoring, therapeutic, and/or diagnostic capabilities with respect to the organ.